The early onset of L-type calcium channel-mediated pretangle tau pathology and rectification by nimodipine in our model have significant implications for preclinical Alzheimer’s disease prevention and intervention. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.